Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-12
2007-06-12
Tran, Susan (Department: 1615)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S362000, C424S451000, C424S464000
Reexamination Certificate
active
10498548
ABSTRACT:
This invention relates to compounds of Formula (I) and the use of compounds of Formula (I) as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
REFERENCES:
patent: 5604202 (1997-02-01), Kessler et al.
patent: 1 464 259 (1977-02-01), None
Scozzafava, A. and Supuran, C.T., “Complexes with Biologically Active Ligands. Part 101Inhibition of Carbonic Anhydrase Isozymes I and II with Metal Complexes of Imidazo[2,1-b]-1,3,4-Thiadiazole-2-Sulfonamide,” XP-002232873, vol. 4(1): 19-26 (1997).
Barnish, Ian T., et al., “Cerebrovasodilatation Through Selective Inhibition of the Enzyme Carbonic Anhydrase. 2. Imidazo[2,1-b]thiadiazole and Imidazo[2,1-b]thiazolesulfonamides,”J. Med. Chem.,23: 117-121 (1980).
Khazi, Imtiyaz A.M., et al., “Synthesis, Anticonvulsant and Analgesic Activities of Some 6-Substituted Imidazo(2,1-b)-1,3,4-thiadiazole-2-sulfonamides and Their 5-Bromo Derivatives,”ArzneimForsch Drug Res.(XP-002232875), 46:949-952 (1996).
Conroy, Curtis W., et al., “The Nonenzymatic Displacement of the Sulfamoyl Group From Different Classes of Aromatic Compounds by Glutathione and Cysteine,”Drug Metabolism and Disposition(XP009006657), 12(5): 614-618 (1984).
Gadad, Andanappa K., et al., “Synthesis and Antibacterial Activity of Some 5-Guanylhydrazone/thiocyanato-6-arylimidazo[2,1-b]-1,3,4-thiadiazole-2-sulfonamide Derivatives,”Eur. J. Med. Chem.,35: 853-857 (2000).
Gadad, Andanappa K., et al., “Synthesis and Biological Evaluation of 5-Formyl-6-arylimidazo(2,1-b)-1,3,4-thiadiazole-2-N-(dimethyl-aminomethino)sulfonamides as Antitumor Agents,”Arzneim.-Forsch./Drug Res.,49(II), Nr. 10: 858-863 (1999).
Supuran, C.T., “Metal Complexes of 1,3,4-Thiadiazole-2,5-Disulfonamide Are Strong Dual Carbonic Anhydrase Inhibitors, Although the Ligand Possesses Very Weak Such Properties,” XP-1002232877, vol. 2(6): 331-336 (1995).
Boudreault Alain
Durkin Jon
Gillard John W.
Hewitt Kimberly
Jaquith James B.
Aegera Therapeutics Inc.
Elmore Carolyn S.
Elmore Patent Law Group P.C.
Tran Susan
Vanstone Darlene A.
LandOfFree
Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3850058